Su Zhou BionovoShine Pharmaceutical Co., Ltd, registered in October 2016, is a Sino-foreign joint venture innovative biomedical enterprise established by BionovoH and foreign scientists, specializing in the research, registration, production, sales and service of gene editing therapy and gene therapy related products. Starting from the treatment of blood genetic diseases, the company establishes its own gene therapy drug technology platform, and further develop and distributes gene therapy drugs for cancer, liver and muscle genetic diseases.

At present, the company has developed a gene therapy drug technology platform for hereditary blood diseases. The first batch of gene therapy drugs for hemophilia A/B has made breakthrough progress, and has developed gene therapy drugs for long-acting and permanent cure. Follow-up innovative products are being developed.